PDL BioPharma, Inc. Shares (Common)

Shares (Common) of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Shares (Common) growth rates and interactive chart. Number of common shares outstanding in a company.


Highlights and Quick Summary

  • Shares (Common) for the quarter ending June 29, 2020 was $114 Million (a -5.45% decrease compared to previous quarter)
  • Year-over-year quarterly Shares (Common) decreased by -0.21%
  • Annual Shares (Common) for 2019 was $124 Million (a -8.94% decrease from previous year)
  • Annual Shares (Common) for 2018 was $137 Million (a -11.23% decrease from previous year)
  • Annual Shares (Common) for 2017 was $154 Million (a -7.11% decrease from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Shares (Common) of PDL BioPharma, Inc.

Most recent Shares (Common)of PDLI including historical data for past 10 years.

Interactive Chart of Shares (Common) of PDL BioPharma, Inc.

PDL BioPharma, Inc. Shares (Common) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $113.95 $120.52
2019 $124.3 $114.19 $115.67 $123.82 $124.3
2018 $136.51 $145.98 $145.97 $152.81 $136.51
2017 $153.78 $154.34 $154.08 $163.72 $153.78
2016 $165.54 $165.54 $165.54 $165.12 $165.54
2015 $164.29 $163.57 $163.56 $163.53 $164.29
2014 $162.19 $160.28 $160.27 $160.23 $162.19
2013 $139.94 $139.85 $139.85 $139.82 $139.94
2012 $139.82 $139.72 $139.71 $139.68 $139.82
2011 $139.68 $139.68 $139.8 $139.64 $139.68
2010 $139.64 $139.53 $119.56 $139.64

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.